Hyaluronan Inhibition as a Therapeutic Target for Diabetic Kidney Disease: What Is Next?

Diabetic kidney disease (DKD) is the leading cause of CKD and ESKD in the United States and worldwide. Pharmacotherapy and lifestyle modifications for glycemia, dyslipidemia, and BP control have shown success in slowing the progression of DKD. Traditional treatments, such as angiotensin-converting e...

Descripción completa

Detalles Bibliográficos
Autores principales: Salman, Loay, Martinez, Laisel, Faddoul, Geovani, Manning, Christina, Ali, Karim, Salman, Maya, Vazquez-Padron, Roberto
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Society of Nephrology 2023
Materias:
Review Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10371374/
https://www.ncbi.nlm.nih.gov/pubmed/37055910
http://dx.doi.org/10.34067/KID.0000000000000126

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10371374/
https://www.ncbi.nlm.nih.gov/pubmed/37055910
http://dx.doi.org/10.34067/KID.0000000000000126

Ejemplares similares